Webinar Abstract: Understanding Anti-Xa Assays for Heparin and Direct Oral Anticoagulant (DOAC) Testing
In the evolving landscape of anticoagulation management, anti-Xa assays have emerged as critical tools for monitoring and assessing both heparin therapy and direct oral anticoagulants (DOACs). This webinar will provide a comprehensive overview of anti-Xa testing, including its clinical applications, advantages over traditional coagulation tests, and best practices for laboratory implementation.
Key topics will include:
- Principles of Anti-Xa Assays: How they work and their role in anticoagulation monitoring.
- Heparin Monitoring: Differences between unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) testing.
- DOAC Testing: When and why anti-Xa assays are used for rivaroxaban, apixaban, and edoxaban measurement.
- Laboratory Best Practices: Standardization, assay selection, and quality control considerations.
This session is designed for laboratory professionals, clinicians, and pharmacists involved in anticoagulation therapy and laboratory diagnostics. Attendees will gain valuable insights into optimizing anti-Xa testing to enhance patient care and treatment decisions.
Join us to explore the critical role of anti-Xa assays in modern anticoagulation management!
Event Details:
📅 Date: April 29th, 2025
⏰ Time: 1PM EST
📍 Location: Live Virtual Event
Don’t Miss Out – Secure Your Spot Today!
Sponsored by
Medqor is committed to protecting and respecting your privacy. We may contact you about our products and services or share information with sponsorship partners, as well as other content that may be of interest to you. By submitting your information, you consent to us contacting you for this purpose in accordance with our privacy policy.
For further information, please check out our privacy policy here
